Farther Finance Advisors’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-59
Closed -$5.8K 4965
2025
Q2
$5.8K Buy
59
+4
+7% +$378 ﹤0.01% 3302
2025
Q1
$5.11K Sell
55
-19
-26% -$1.75K ﹤0.01% 3052
2024
Q4
$6.72K Sell
74
-18
-20% -$1.65K ﹤0.01% 2544
2024
Q3
$8.88K Buy
92
+18
+24% +$1.76K ﹤0.01% 2414
2024
Q2
$7.15K Buy
74
+33
+80% +$3.06K ﹤0.01% 2219
2024
Q1
$3.79K Sell
41
-19
-32% -$1.78K ﹤0.01% 2196
2023
Q4
$5.7K Buy
60
+48
+400% +$4.48K ﹤0.01% 1895
2023
Q3
$1.12K Hold
12
﹤0.01% 2052
2023
Q2
$1.1K Hold
12
﹤0.01% 1944
2023
Q1
$883 Sell
12
-47
-80% -$4.07K ﹤0.01% 1877
2022
Q4
$4.93K Buy
+59
New +$5.32K ﹤0.01% 1173

Other funds holding AMED

Farther Finance Advisors's AMED Position: Q3 2025 in Review

Farther Finance Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 59 shares — an estimated $5.8K sold.

Farther Finance Advisors first reported a position in AMED in Q4 2022 and held it in 11 quarters. The position peaked at $8.88K in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Farther Finance Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 59 Amedisys shares in Q3 2025, an estimated $5.8K.
  • Farther Finance Advisors first reported a position in Amedisys in Q4 2022 and held it in 11 quarters.
  • Farther Finance Advisors's Amedisys position peaked at $8.88K in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Farther Finance Advisors's 13F filing for Q3 2025, filed 14 Oct 2025.